Clinical Trials, Mergers and Acquisitions, Research and Development
March 10, 2023
Via: Contract PharmaLEO Pharma, a global leader in medical dermatology, and ICON plc, entered into a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, to support the company’s clinical portfolio. The partnership […]
Industry, Mergers and Acquisitions, Vaccines
March 9, 2023
Via: PMLiVEThe partnership will see both companies advance MDX-2201 to an Investigational New Drug application filing, after which Merck will be responsible for clinical and regulatory activities, as well as product commercialisation. In exchange, Opko will receive an upfront payment of […]
March 6, 2023
Via: Biopharma DiveThe deal highlights the funding difficulties that development-stage biotechnology companies continue to face amid a sector-wide downturn that has weakened investor interest. This has led to a spate of layoffs and consolidation across the industry. Before the companies’ respective layoffs […]
February 24, 2023
Via: Biopharma DiveRoche is terminating its collaboration with biotechnology company Blueprint Medicine and handing back commercial rights to its lung cancer treatment Gavreto. The move comes weeks after the Swiss drugmaker took impairment charges worth 663 million Swiss francs, or about $706 […]
February 17, 2023
Via: Contract PharmaLIfT BioSciences, a pre-clinical stage company moving into first-in-human trials with an allogeneic neutrophil progenitor based cell therapy, and Minaris Regenerative Medicine GmbH, a global contract development and manufacturing organization (CDMO) provider for the cell and gene therapy industry, have […]
Cell and Gene Therapy, Industry, Mergers and Acquisitions
February 16, 2023
Via: Contract PharmaCharles River Laboratories International, and Purespring Therapeutics, a gene therapy company focused on transforming the treatment of kidney diseases, announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration. Supporting the first gene therapy platform targeting renal diseases, that […]
February 16, 2023
Via: PMLiVEThe companies will still continue to work together on their SARS-CoV-2-targeting antibody, sotrovimab, in markets where it is authorised, as well as their experimental COVID-19 antibody, VIR-7832, and a portfolio of other therapies for respiratory diseases such as influenza. Originally […]
February 15, 2023
Via: Biopharm InternationalGenScript ProBio, a US-based contract development and manufacturing organization specializing in biologics, and Bio Immunitas, a UK-based pharmaceutical company, announced a joint collaboration on Feb. 8, 2023. The aim of this partnership is to develop and fast track manufacturing of […]
February 13, 2023
Via: Biopharm InternationalOn Feb. 7 2023, Elektrofi, a biotechnology company focused on drug formulation and delivery innovations, announced a contract manufacturing agreement with Thermo Fisher Scientific to support the manufacturing of Elektrofi’s ultra-high concentration subcutaneous products. The technology is designed to enable […]
February 8, 2023
Via: Contract PharmaBattelle, Amplify, and Andelyn Biosciences, have won a seat on an eight-year, $149 million indefinite delivery, indefinite quantity (IDIQ) contract vehicle for the National Institute of Neurological Disorders and Stroke. As one of the prime contractors on the multi-award IDIQ, […]
February 7, 2023
Via: Contract PharmaGenenta Science, a clinical-stage biotechnology company engaged in the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, has entered into a development and manufacturing service agreement (MSA) with AGC Biologics S.p.A. to manufacture cell therapy lentivirus-based product for […]
February 7, 2023
Via: Contract PharmaElektrofi, a biotechnology company focused on drug formulation and delivery innovations, announced a strategic contract manufacturing agreement with Thermo Fisher Scientific to support clinical manufacture of Elektrofi’s breakthrough ultra-high concentration subcutaneous products. Elektrofi’s platform technology is designed to overcome the […]
February 6, 2023
Via: Biopharm InternationalThermo Fisher Scientific recently announced that it had become a founding sponsor of Momentum Labs, a collaborative laboratory and office space to be located in Alachua, Fla. The venture, spearheaded by Gainesville real estate development firm Concept Companies, is designed […]
Clinical Trials, Mergers and Acquisitions, Research and Development
February 3, 2023
Via: Pharma TimesAardex Group – a company focused on remote research and healthcare adherence – and Cambridge Cognition have firmed a partnership up to provide monitoring during hybrid and decentralised clinical trials (DCTs). The link-up will involve the incorporation of Aardex’s MEMS […]
Cell and Gene Therapy, Industry, Mergers and Acquisitions
February 1, 2023
Via: Contract PharmaAndelyn Biosciences, a gene therapy contract development and manufacturing organization (CDMO), has partnered with Odylia Therapeutics, a nonprofit 501(c)(3) biotech focused on accelerating rare disease drug development, to manufacture a novel gene therapy (OT-004) to treat vision loss caused by […]
January 26, 2023
Via: PharmaphorumRoche’s alliance with France’s Sysnav Healthcare is in the area of movement disorders, and will build on the tech company’s wearable magneto-inertial sensor device for 3D movement tracking, which has already been accepted as a digital endpoint for use in […]
January 25, 2023
Via: Contract PharmaStevanato Group S.p.A., a global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, has entered a collaboration with Transcoject GmbH, a medical device and pharma packaging solutions company. The collaboration will enable Stevanato […]
January 24, 2023
Via: PharmaphorumThe partnership between Sanofi and CytoReason – for an undisclosed, multimillion dollar amount – forms part of an ongoing collaboration begun in 2021, which originally focused on obtaining advanced mechanistic insights for asthma endotypes. The collaboration takes CytoReason’s partnering with […]
January 23, 2023
Via: Contract PharmaSyner-G BioPharma Group, a provider of pharmaceutical science and regulatory consulting services, has acquired RMC Pharmaceutical Solutions (RMC). RMC supports the outsourced CMC and Quality needs of biotech and pharma companies across multiple therapeutic areas. Financial terms were not disclosed. […]
January 20, 2023
Via: Contract PharmaCharles River Laboratories International Inc. and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, have announced a viral vector contract development and manufacturing organization (CDMO) partnership. Rznomics will leverage Charles River’s viral vector […]